Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Miss Charlotte Vrinten
Room 204
Visiting address: 1-19 Torrington Place
Postal address: UCL, Gower Street
Tel: (+44) 020 7679 41735
  • Research Assistant
  • Epidemiology & Public Health
  • Institute of Epidemiology & Health
  • Faculty of Pop Health Sciences

Charlotte has a background in medicine, psychology, and philosophy. Her thesis projects included an investigation into the possibility of withdrawing diabetes treatment in the very elderly to increase quality of life in the last life years and the role of moral responsibility for disease in the treatment of overweight and obese diabetes patients.

Her research interests cover a range of topics and include non-communicable diseases, health behaviour, information processing, healthcare policy, access to healthcare, research and medical ethics, and rationale for treatment.

Research Groups
Research Themes
Research Summary

Charlotte works on a project about cancer fear at the Health Behaviour Research Centre of the Department of Epidemiology and Public Health. This project, which is funded by Cancer Research UK, focuses on the role of cancer fear in relation to early detection behaviours and
participation in cancer screening.

She is also writing up the results of her PhD, which investigates whether a research design n-of-one trials -conducted in small series- can facilitate research into off-label medicines for rare diseases. She investigated whether the (serial) n-of-one trial design can be used to circumvent the problem of there being only a few patients available to participate in clinical trials, and whether the pooled results of these n-of-one trials can be used to draft treatment guidelines and decide on market approval and reimbursement of these treatments for these patients. The case of (rare) neuromuscular diseases was used as an example.

Academic Background
2010 BA Bachelor of Arts – Philosophy Universiteit Utrecht
2010 BSc Bachelor of Science – Psychology Universiteit Utrecht
2010 MSc Master of Science – Medicine Universiteit Utrecht
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by